GLP-1 receptor agonists such as semaglutide and tirzepatide are transforming weight and metabolic health. This article explores the benefits, rare pancreatitis risks, MHRA Yellow Card data, genetic research, and how robust clinical governance and monitoring help ensure safe, evidence-based treatment for appropriately selected patients in the UK.

The Dangers of Unregulated Weight Loss Injections A recent incident in Selby, North Yorkshire, highlighted the serious risks of unregulated weight loss injections. Three women were arrested after a local woman suffered internal injuries and required intensive care following a “skinny jab” administered at a salon. This case highlights the potential dangers of obtaining weight loss treatments from unauthorised sources. Health officials emphasise that weight loss medications, s